Cargando…

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis

BACKGROUND: The coronavirus disease (COVID-19) epidemic has not been completely controlled. Although great achievements have been made in COVID-19 research and many antiviral drugs have shown good therapeutic effects against COVID-19, a simple oral antiviral drug for COVID-19 has not yet been develo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Wen, Chen, Chen, Tang, Jiake, Wang, Chunyi, Zhou, Mengyun, Cheng, Yongran, Zhou, Xiang, Wu, Qi, Zhang, Xingwei, Feng, Zhanhui, Wang, Mingwei, Mao, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820829/ https://www.ncbi.nlm.nih.gov/pubmed/35118917 http://dx.doi.org/10.1080/07853890.2022.2034936

Ejemplares similares

Efficacy and safety of Paxlovid for COVID-19:a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

A meta-analysis of the association between calprotectin and the severity of COVID-19
por: Mao, Qin, et al.
Publicado: (2022)

Explore the attitudes of children and adolescent parents towards the vaccination of COVID-19 in China
por: Wang, Lin, et al.
Publicado: (2022)

Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis
por: Xu, Wencheng, et al.
Publicado: (2022)

Post-COVID-19 fatigue among COVID-19 in patients discharged from hospital: A meta-analysis
por: Ji, Guohua, et al.
Publicado: (2022)

Meta-analysis of post-traumatic stress disorder and COVID-19 in patients discharged
por: Chen, Chen, et al.
Publicado: (2022)

Efficacy and safety of outpatient parenteral antibiotic therapy in patients with infective endocarditis: a meta-analysis
por: Wen, Wen, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
por: Wen, Wen, et al.
Publicado: (2022)

Medical emergency calls and calls for central nervous system symptoms during the COVID-19 outbreak in Hangzhou, China
por: Fu, Xinyan, et al.
Publicado: (2022)

An Overview of Fluvoxamine and its Use in SARS-CoV-2 Treatment
por: Arishi, Naif A, et al.
Publicado: (2023)

COVID-19 Rebound After Paxlovid Treatment: A Case Series and Review of Literature
por: Alshanqeeti, Shatha, et al.
Publicado: (2022)

On the choice of Molnupiravir and Paxlovid as the only antivirals permitted for COVID-19 infection in Australia
por: Boretti, Alberto
Publicado: (2023)

Multidrug-resistant infection in COVID-19 patients: A meta-analysis
por: Hu, Siqi, et al.
Publicado: (2023)

Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir
por: Parums, Dinah V.
Publicado: (2022)

Food Safety Knowledge, Attitudes, and Self-Reported Practices Among Medical Staff in China Before, During and After the COVID-19 Pandemic
por: Luo, Lin, et al.
Publicado: (2021)

Olfactory dysfunction after COVID‐19: metanalysis reveals persistence in one-third of patients 6 months after initial infection
por: Hu, Siqi, et al.
Publicado: (2023)

COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022
por: Wang, Lindsey, et al.
Publicado: (2022)

Psychological stress; knowledge, attitude and practice and acceptance of antiviral therapy in pregnant women with hepatitis B in Zhejiang, China: a case comparison study
por: Liu, Xiaoxiao, et al.
Publicado: (2022)

Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial
por: Flicoteaux, Remi, et al.
Publicado: (2017)

Molecular Modeling and Preliminary Clinical Data Suggesting Antiviral Activity for Chlorpheniramine (Chlorphenamine) Against COVID-19
por: Black, Shaun D
Publicado: (2022)

Multimodal Treatment of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antivirals
por: Mercan-Stanciu, Adriana, et al.
Publicado: (2022)

Antiviral Activity of Svarnvir-IV Tablet Assayed for Activity Against SARS-CoV-2 In Vitro
por: Reddy, K. Ramachandra, et al.
Publicado: (2023)

Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters
por: Bakos, Éva, et al.
Publicado: (2023)

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
por: Gbinigie, Oghenekome, et al.
Publicado: (2023)

Managing COVID-19 infection in a Young Acute Myeloid Leukemia Patient Successfully With Antiviral and Granulocyte Colony Stimulating Factor: Playing on a Sticky Wicket
por: Talwar, Dhruv, et al.
Publicado: (2021)

COVID-19 Virus Infection in Three Patients With Hypogammaglobulinemia
por: Gesiotto, Quinto, et al.
Publicado: (2021)

A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients
por: Kumar, Lakshin, et al.
Publicado: (2023)

Sequential symptomatic analysis in probable severe acute respiratory syndrome cases()
por: Chen, Shey-Ying, et al.
Publicado: (2004)

Association between hepatitis C virus infection and osteoporotic fracture risk among postmenopausal women: a cross-sectional investigation in Taiwan
por: Lin, Ming-Shyan, et al.
Publicado: (2019)

Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors
por: Chen, Yen-Wen, et al.
Publicado: (2022)

Antibiotics for uncomplicated skin abscesses: systematic review and network meta-analysis
por: Wang, Wen, et al.
Publicado: (2018)

Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity
por: Yip, Ashley Jia Wen, et al.
Publicado: (2022)

Pfizer, résultats très prometteurs de l’antiviral oral paxlovid
por: Manus, Jean-Marie
Publicado: (2022)

COVID-19 in Patients With Hematologic-Oncologic Risk Factors: Complications in Three Patients
por: Tafti, Dawood, et al.
Publicado: (2020)

The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials
por: Wang, Shou Zhen, et al.
Publicado: (2014)

Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study
por: Wang, Fei, et al.
Publicado: (2023)

Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study
por: Bi, DeWu, et al.
Publicado: (2023)

A multicentre observational study on neonates exposed to SARS-CoV-2 in China: the Neo-SARS-CoV-2 Study protocol
por: Xiao, Tiantian, et al.
Publicado: (2020)

Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan
por: Matsumoto, Tetsuya, et al.
Publicado: (2021)

Pneumocystis jirovecii Pneumonia in Three Patients With Breast Cancer Receiving Neoadjuvant Dose-Dense Chemotherapy
por: Shiiba, Ritsuya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_svqgpovcdf11jq1e541ebugk96